Dr Sarah Warnes

On copper, and a range of copper alloys – collectively termed ‘antimicrobial copper’ – the coronavirus was rapidly inactivated (within a few minutes, for simulated fingertip contamination). Exposure to copper destroyed the virus completely and irreversibly, leading the researchers to conclude that antimicrobial copper surfaces could be employed in communal areas and at any mass gatherings to help reduce the spread of respiratory viruses and protect public health.

Lead researcher Dr Sarah Warnes said: “Transmission of infectious diseases via contaminated surfaces is far more important than was originally thought, and this includes viruses that cause respiratory infections. This is especially important when the infectious dose is low and just a few virus particles can initiate an infection.

“Human coronavirus, which also has ancestral links with bat-like viruses responsible for SARS and MERS, was found to be permanently and rapidly deactivated upon contact with copper. What’s more, the viral genome and structure of the viral particles were destroyed, so nothing remained that could pass on an infection. With the lack of antiviral treatments, copper offers a measure that can help reduce the risk of these infections spreading.”

Professor Bill Keevil

Speaking on the importance of the study, Professor Bill Keevil, co-author and Chair in Environmental Healthcare at the University of Southampton, said: “Respiratory viruses are responsible for more deaths, globally, than any other infectious agent. The evolution of new respiratory viruses, and the re-emergence of historic virulent strains, poses a significant threat to human health.

“The rapid inactivation and irreversible destruction of the virus observed on copper and copper alloy surfaces suggests that the incorporation of copper alloy surfaces – in conjunction with effective cleaning regimes and good clinical practice – could help control transmission of these viruses.”

Previous research by Professor Keevil and Dr Warnes has proved copper’s efficacy against norovirus, influenza and hospital superbugs, such as MRSA and Klebsiella, plus stopping the transfer of antibiotic resistance genes to other bacteria to create new superbugs.